327 related articles for article (PubMed ID: 24037724)
41. Deleterious Effect of Steroids on Cytomegalovirus Infection Rate after Allogeneic Stem Cell Transplantation Depends on Pretransplant Cytomegalovirus Serostatus of Donors and Recipients.
Suárez-Lledó M; Martínez-Cibrián N; Gutiérrez-García G; Dimova-Svetoslavova V; Marcos MA; Martín-Antonio B; Martínez-Trillos A; Villamor N; Rosiñol L; Martínez C; Fernández-Avilés F; García-Vidal C; Urbano-Ispizua Á; Rovira M
Biol Blood Marrow Transplant; 2018 Oct; 24(10):2088-2093. PubMed ID: 29753162
[TBL] [Abstract][Full Text] [Related]
42. Prognostic impact of viral reactivations in acute myeloid leukemia patients undergoing allogeneic stem cell transplantation in first complete response.
Guenounou S; Borel C; Bérard E; Yon E; Fort M; Mengelle C; Bertoli S; Sarry A; Tavitian S; Huguet F; Attal M; Récher C; Huynh A
Medicine (Baltimore); 2016 Nov; 95(48):e5356. PubMed ID: 27902595
[TBL] [Abstract][Full Text] [Related]
43. Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation.
Nakamura R; Gendzekhadze K; Palmer J; Tsai NC; Mokhtari S; Forman SJ; Zaia JA; Senitzer D; Marcucci G; Stein A
Leuk Res; 2019 Dec; 87():106230. PubMed ID: 31644966
[TBL] [Abstract][Full Text] [Related]
44. Virus reactivation and low dose of CD34+ cell, rather than haploidentical transplantation, were associated with secondary poor graft function within the first 100 days after allogeneic stem cell transplantation.
Sun YQ; Wang Y; Zhang XH; Xu LP; Liu KY; Yan CH; Liu ZY; Huang XJ
Ann Hematol; 2019 Aug; 98(8):1877-1883. PubMed ID: 31144019
[TBL] [Abstract][Full Text] [Related]
45. Cytomegalovirus-specific CD8+ T-cells are associated with a reduced incidence of early relapse after allogeneic stem cell transplantation.
Varanasi PR; Ogonek J; Luther S; Dammann E; Stadler M; Ganser A; Borchers S; Hambach L; Weissinger EM
PLoS One; 2019; 14(3):e0213739. PubMed ID: 30889204
[TBL] [Abstract][Full Text] [Related]
46. Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia.
Ruggeri A; Labopin M; Sanz G; Piemontese S; Arcese W; Bacigalupo A; Blaise D; Bosi A; Huang H; Karakasis D; Koc Y; Michallet M; Picardi A; Sanz J; Santarone S; Sengelov H; Sierra J; Vincent L; Volt F; Nagler A; Gluckman E; Ciceri F; Rocha V; Mohty M; ;
Leukemia; 2015 Sep; 29(9):1891-900. PubMed ID: 25882700
[TBL] [Abstract][Full Text] [Related]
47. Risk Factors for Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation in Malignancies: Proposal for Classification.
Dziedzic M; Sadowska-Krawczenko I; Styczynski J
Anticancer Res; 2017 Dec; 37(12):6551-6556. PubMed ID: 29187429
[TBL] [Abstract][Full Text] [Related]
48. Graft-versus-leukaemia activity associated with cytomegalovirus seropositive bone marrow donors but separated from graft-versus-host disease in allograft recipients with AML.
Jacobsen N; Lönnqvist B; Ringdén O; Rajantie J; Siimes MA; Volin L; Ruutu T; Nikoskelainen J; Toivanen A; Ryder L
Eur J Haematol; 1987 Apr; 38(4):350-5. PubMed ID: 3038601
[TBL] [Abstract][Full Text] [Related]
49. Persistent CMV infection after allogeneic hematopoietic stem cell transplantation in a CMV-seronegative donor-to-positive recipient constellation: Development of multidrug resistance in the absence of anti-viral cellular immunity.
Herling M; Schröder L; Awerkiew S; Chakupurakal G; Holtick U; Kaiser R; Pfister H; Scheid C; Di Cristanziano V
J Clin Virol; 2016 Jan; 74():57-60. PubMed ID: 26672492
[TBL] [Abstract][Full Text] [Related]
50. Delayed NK Cell Reconstitution and Reduced NK Activity Increased the Risks of CMV Disease in Allogeneic-Hematopoietic Stem Cell Transplantation.
Park KH; Ryu JH; Bae H; Yun S; Jang JH; Han K; Cho BS; Kim HJ; Lee H; Oh EJ
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455959
[TBL] [Abstract][Full Text] [Related]
51. Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the acute leukemia working party (ALWP) of the European group of blood and marrow transplantation (EBMT).
Poiré X; Labopin M; Cornelissen JJ; Volin L; Richard Espiga C; Veelken JH; Milpied N; Cahn JY; Yacoub-Agha I; van Imhoff GW; Michallet M; Michaux L; Nagler A; Mohty M
Am J Hematol; 2015 Aug; 90(8):719-24. PubMed ID: 26010466
[TBL] [Abstract][Full Text] [Related]
52. The use of ATG abrogates the antileukemic effect of cytomegalovirus reactivation in patients with acute myeloid leukemia receiving grafts from unrelated donors.
Busca A; Passera R; Pini M; Zallio F; Dellacasa C; Audisio E; Giaccone L; Maffini E; Costa C; Cavallo R; Bruno B
Am J Hematol; 2015 Jun; 90(6):E117-21. PubMed ID: 25752810
[TBL] [Abstract][Full Text] [Related]
53. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality.
Liu J; Kong J; Chang YJ; Chen H; Chen YH; Han W; Wang Y; Yan CH; Wang JZ; Wang FR; Chen Y; Zhang XH; Xu LP; Liu KY; Huang XJ
Clin Microbiol Infect; 2015 Dec; 21(12):1121.e9-15. PubMed ID: 26093077
[TBL] [Abstract][Full Text] [Related]
54. Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: superior outcomes compared with chemotherapy alone and an analysis of prognostic factors.
Yan CH; Wang JZ; Liu DH; Xu LP; Chen H; Liu KY; Huang XJ
Eur J Haematol; 2013 Oct; 91(4):304-14. PubMed ID: 23837640
[TBL] [Abstract][Full Text] [Related]
55. Predictors of cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: Insights from a real-world experience.
McGuirk M; Shahzad M; Amin MK; Khan MA; Bellman P; Mudaranthakam DP; DeJarnette S; Lutfi F; Ahmed N; Bansal R; Abdelhakim H; Gorsline C; Shoemaker DM; Abdallah AO; Shune L; Abhyankar SH; Singh AK; McGuirk JP; Mushtaq MU
Transpl Immunol; 2024 Jun; 84():102039. PubMed ID: 38513813
[TBL] [Abstract][Full Text] [Related]
56. Comparable Long-Term Outcome after Allogeneic Stem Cell Transplantation from Sibling and Matched Unrelated Donors in Patients with Acute Myeloid Leukemia Older Than 50 Years: A Report on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Shimoni A; Labopin M; Savani B; Byrne M; Volin L; Finke J; Niederwieser D; Ehninger G; Blaise D; Beelen D; Tabrizi R; Sengeloev H; Ganser A; Cornelissen JJ; Mohty M; Nagler A
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2251-2260. PubMed ID: 31271887
[TBL] [Abstract][Full Text] [Related]
57. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis.
Teira P; Battiwalla M; Ramanathan M; Barrett AJ; Ahn KW; Chen M; Green JS; Saad A; Antin JH; Savani BN; Lazarus HM; Seftel M; Saber W; Marks D; Aljurf M; Norkin M; Wingard JR; Lindemans CA; Boeckh M; Riches ML; Auletta JJ
Blood; 2016 May; 127(20):2427-38. PubMed ID: 26884374
[TBL] [Abstract][Full Text] [Related]
58. The adverse events of haematopoietic stem cell transplantation are associated with gene polymorphism within human leukocyte antigen region.
Chen DP; Wen YH; Wang PN; Hour AL; Lin WT; Hsu FP; Wang WT
Sci Rep; 2021 Jan; 11(1):1475. PubMed ID: 33446692
[TBL] [Abstract][Full Text] [Related]
59. Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT.
Cesaro S; Crocchiolo R; Tridello G; Knelange N; Van Lint MT; Koc Y; Ciceri F; Gülbas Z; Tischer J; Afanasyev B; Bruno B; Castagna L; Blaise D; Mohty M; Irrera G; Diez-Martin JL; Pierelli L; Pioltelli P; Arat M; Delia M; Fagioli F; Ehninger G; Aljurf M; Carella AM; Ozdogu H; Mikulska M; Ljungman P; Nagler A; Styczynski J
Bone Marrow Transplant; 2018 Apr; 53(4):422-430. PubMed ID: 29330396
[TBL] [Abstract][Full Text] [Related]
60. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.
Webb BJ; Harrington R; Schwartz J; Kammerer J; Spalding J; Lee E; Dodds B; Kaufusi S; Goodman BE; Firth SD; Martin G; Sorensen J; Hoda D
Transpl Infect Dis; 2018 Oct; 20(5):e12961. PubMed ID: 29975816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]